{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:03:17Z","timestamp":1789124597148,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070963"],"award-info":[{"award-number":["81070963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2010HM019"],"award-info":[{"award-number":["ZR2010HM019"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jneuroim.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T09:55:08Z","timestamp":1467539708000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3125-2855","authenticated-orcid":false,"given":"Yu","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir Olve","family":"Skeie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Romi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jone Furlund","family":"Owe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.07.001_bb0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis - a comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2014.05.037","article-title":"Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population","volume":"343","author":"Chang","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0015","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1007\/s11033-012-1788-4","article-title":"Association between CTLA-4 exon-1 +49A\/G polymorphism and systemic lupus erythematosus: an updated analysis","volume":"39","author":"Chang","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0020","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1538-7836.2012.04815.x","article-title":"Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease","volume":"10","author":"Chen","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0025","first-page":"258","article-title":"Case report of a MG patient with both AChR and MuSK antibodies","volume":"28","author":"Cui","year":"2015","journal-title":"Lin Chuang Shen Jing Bing Xue Za Zhi"},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0030","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10072-012-1159-x","article-title":"The high frequency and clinical feature of seronegative myasthenia gravis in southern China","volume":"34","author":"Feng","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0040","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0045","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","article-title":"Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies","volume":"57","author":"Giraud","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114060","article-title":"Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development","volume":"9","author":"Heldal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cccn.2005.05.035","article-title":"A sensitive non-isotopic assay for acetylcholine receptor autoantibodies","volume":"364","author":"Hewer","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0060","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1515\/cclm-2013-1021","article-title":"Effect of storage conditions and freeze\/thaw cycles on serum and plasma levels of anti-acetylcholine receptor (AChR) antibody","volume":"52","author":"Hong","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory Board of the Myasthenia Gravis Foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0070","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2015.07.030","article-title":"An update on laboratory diagnosis in myasthenia gravis","author":"Oger","year":"2015","journal-title":"Clinica Chimica Acta; International Journal of Clinical Chemistry"},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1468-1331.2002.00352.x","article-title":"Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis","volume":"9","author":"Romi","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0085","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archneur.57.11.1596","article-title":"The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies","volume":"57","author":"Romi","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archneur.62.3.442","article-title":"Striational antibodies in myasthenia gravis: reactivity and possible clinical significance","volume":"62","author":"Romi","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0095","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"Skeie","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0100","article-title":"CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0105","doi-asserted-by":"crossref","first-page":"740583","DOI":"10.4061\/2011\/740583","article-title":"Three types of striational antibodies in myasthenia gravis","volume":"2011","author":"Suzuki","year":"2011","journal-title":"Autoimmune Diseases"},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ane.12271","article-title":"Antititin antibody in early- and late-onset myasthenia gravis","volume":"130","author":"Szczudlik","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/mus.24213","article-title":"Health-related quality-of-life and treatment targets in myasthenia gravis","volume":"50","author":"Utsugisawa","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0130","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10072-013-1329-5","article-title":"A cohort study on myasthenia gravis patients in China","volume":"34","author":"Wang","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0135","first-page":"2555","article-title":"Detection of multiple antibodies in myasthenia gravis and its clinical significance","volume":"123","author":"Wang","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0140","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jocn.2011.05.002","article-title":"Association between HLA-DRB1 and myasthenia gravis in a northern Han Chinese population","volume":"18","author":"Xie","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2016.07.001_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2013.12.012","article-title":"AChR-myasthenia gravis switching to double-seropositive several years after the onset","volume":"267","author":"Zouvelou","year":"2014","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816301448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816301448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:44Z","timestamp":1759048064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816301448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":29,"alternative-id":["S0165572816301448"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.07.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}